Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model

INTRODUCTION: The coronavirus disease 2019 (COVID-19) pandemic continues to cause significant morbidity and mortality worldwide. Since a large portion of the world’s population is currently unvaccinated or incompletely vaccinated and has limited access to approved treatments against COVID-19, there...

Descripción completa

Detalles Bibliográficos
Autores principales: Péricat, D., Leon-Icaza, S. A., Sánchez-Rico, M., Mühle, C., Zoicas, I., Schumacher, F., Planès, R., Mazars, R., Gros, G., Carpinteiro, A., Becker, K. A., Izopet, J., Strub-Wourgaft, N., Sjö, P., Neyrolles, O., Kleuser, B., Limosin, F., Gulbins, E., Kornhuber, J., Meunier, E., Hoertel, N., Cougoule, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595818/
http://dx.doi.org/10.1192/j.eurpsy.2023.318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595818/
http://dx.doi.org/10.1192/j.eurpsy.2023.318

Ejemplares similares